Appreciate the response, and glad to know that I got the broad strokes correct anyways. Having $2.7mm and erasing some liabilities seems like a much better position than having $1,000 in cash like they did a while back. And yes, dilution is inevitable... but $3mm seems like a song for 80% of the company. Hopefully it allows the company to finish the P2 quickly and move on to applying for BTD and maybe AA. It would be great if you're correct and this dilutive round is enough to get the drug to market. I've seen examples where bit by bit funding in an attempt to minimize dilution has backfired somewhat, so maybe taking your medicine up front is the way to go IF you can get enough cash at once.
Pleased to see the SP holding around .05 today, even if on low volume so far.
News 
Market Data 
Discover 
